186 GSK Annual Report 2018 Notes to the financial statements continued 32.
Contingent liabilities At 31 December 2018, contingent liabilities, comprising guarantees, discounted bills and other items arising in the normal course of business, amounted to 93 million 2017 434 million.
At 31 December 2018, nil 2017 2 million of financial assets were pledged as collateral for contingent liabilities.
Provision is made for the outcome of tax, legal and other disputes where it is both probable that the Group will suffer an outflow of funds and it is possible to make a reliable estimate of that outflow.
At 31 December 2018, other than for those disputes where provision has been made, it was not possible to make a reliable estimate of the potential outflow of funds that might be required to settle disputes where the possibility of there being an outflow was more than remote.
Descriptions of the significant legal and other disputes to which the Group is a party are set out in Note 45, Legal proceedings.
Share capital and share premium account Share Ordinary Shares of 25p each premium Number m m Share capital authorised At 31 December 2016 10,000,000,000 2,500 At 31 December 2017 10,000,000,000 2,500 At 31 December 2018 10,000,000,000 2,500 Share capital issued and fully paid At 1 January 2016 5,361,307,647 1,340 2,831 Issued under employee share schemes 7,008,415 2 87 Ordinary shares acquired by ESOP Trusts 36 At 31 December 2016 5,368,316,062 1,342 2,954 Issued under employee share schemes 4,237,758 1 55 Ordinary shares acquired by ESOP Trusts 10 At 31 December 2017 5,372,553,820 1,343 3,019 Issued under employee share schemes 6,513,804 2 72 At 31 December 2018 5,379,067,624 1,345 3,091 31 December 2018 31 December 2017 000 000 Number of shares issuable under employee share schemes 56,723 38,647 Number of unissued shares not under option 4,564,209 4,588,799 At 31 December 2018, of the issued share capital, 41,530,909 shares were held in the ESOP Trusts, 414,605,950 shares were held as Treasury shares and 4,922,930,765 shares were in free issue.
All issued shares are fully paid.
The nominal, carrying and market values of the shares held in the ESOP Trusts are disclosed in Note 43, Employee share schemes.
